Here you will find our latest news and updates.

May 2019 updates to website


The website has now been updated following May’s LMMG

The following drugs have been added/updated:

Ciclosporin 0.1% / 1 mg/mL eye drops (Verkazia®) — Severe vernal keratoconjunctivitis in children from 4 years of age and adolescents

Azelastine 137 microgram/Fluticasone propionate 50 microgram (120d) (Dymista ®) — Relief of symptoms of moderate to severe seasonal and perennial allergic rhinitis if monotherapy with either intranasal antihistamine or glucocorticoid is not considered sufficient

Certolizumab pegol NICE TA574 — For treating moderate to severe plaque psoriasis

Tildrakizumab NICE TA575 — For treating moderate to severe plaque psoriasis

The following guidelines have been added/updated:

Primary Care Good Prescribing Guide (Version 2.2) — Guidance updated

COPD Guideline (Version 1.8) — Guidance updated

E‑Cigarettes (version 2.0) — Position Statement updated